A Phase 2 trial of 33 enslaves with...
A Phase 2 trial of 33 enslaves with bile duct tumors treated with DEAE-rebeccamycin analogue (XL119 Exelixis, Inc., southward San Francisco, CA) was mannersed in previously untreated subjects with advanced biliary cancers, measurable disease, and normal liver function. make liables were treated with a dose of 165 mg/[msup2] for day for five days, each three weeks. Key
4d Scan , Magnetic Jewelry , Real Estate Loans , Voip Service Provers , Tørre Øyne |